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Discovery of novel geranylgeranyl 
reductases and characterization of their 
substrate promiscuity
Corey W. Meadows1,2†, Florence Mingardon3†, Brett M. Garabedian1,2, Edward E. K. Baidoo1,2, 
Veronica T. Benites1,2, Andria V. Rodrigues1,2, Raya Abourjeily3, Angelique Chanal3 and Taek Soon Lee1,2* 
Abstract 
Background: Geranylgeranyl reductase (GGR) is a flavin-containing redox enzyme that hydrogenates a variety of 
unactivated polyprenyl substrates, which are further processed mostly for lipid biosynthesis in archaea or chlorophyll 
biosynthesis in plants. To date, only a few GGR genes have been confirmed to reduce polyprenyl substrates in vitro or 
in vivo.
Results: In this work, we aimed to expand the confirmed GGR activity space by searching for novel genes that func-
tion under amenable conditions for microbial mesophilic growth in conventional hosts such as Escherichia coli or 
Saccharomyces cerevisiae. 31 putative GGRs were selected to test for potential reductase activity in vitro on farnesyl 
pyrophosphate, geranylgeranyl pyrophosphate, farnesol (FOH), and geranylgeraniol (GGOH). We report the discovery 
of several novel GGRs exhibiting significant activity toward various polyprenyl substrates under mild conditions (i.e., 
pH 7.4, T = 37 °C), including the discovery of a novel bacterial GGR isolated from Streptomyces coelicolor. In addition, 
we uncover new mechanistic insights within several GGR variants, including GGR-mediated phosphatase activ-
ity toward polyprenyl pyrophosphates and the first demonstration of completely hydrogenated GGOH and FOH 
substrates.
Conclusion: These collective results enhance the potential for metabolic engineers to manufacture a variety of iso-
prenoid-based biofuels, polymers, and chemical feedstocks in common microbial hosts such as E. coli or S. cerevisiae.
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© The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Manufacturing of terpenoid-based compounds has been 
studied extensively in synthetic biology. The two bio-
synthetic pathways for terpene monomer biosynthesis 
are the mevalonate and 1-deoxy-d-xylulose 5-phosphate 
pathways, where pyruvate is ultimately converted into 
either of the  C5 terpene building blocks, isopentenyl 
pyrophosphate or dimethylallyl pyrophosphate [1, 2]. 
These monomer units are subsequently fused by various 
prenyl transferases to make geranyl pyrophosphate (GPP, 
 C10), farnesyl pyrophosphate (FPP,  C15), and geranylge-
ranyl pyrophosphate (GGPP,  C20) [3]. The structural 
diversity of terpenes allows for a broad range of uses in 
areas including dietary supplements, polymer feedstocks, 
pharmaceuticals and cosmetics, household cleaners, and 
fuels [4–8]. Much of this structural diversity is achieved 
via downstream cyclization and redox steps on GPP, FPP, 
and GGPP using a plethora of terpene synthases [9–11]. 
Combinations of these core isoprenoid pyrophosphate 
intermediates serve as starting points for cholesterol bio-
synthesis, antibiotic biosynthesis, cofactor biosynthesis, 
and protein prenylation [12–16].
While microbes including E. coli and S. cerevisiae have 
emerged as robust hosts in the production of terpenoids, 
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producing specially tailored natural products will require 
the use of novel chemistries and biosynthetic pathways. 
For example, isoprenoids have been considered as a 
promising precursor of alternative fuels, but reduction of 
isoprenoid double bonds is required to decrease the reac-
tivity and sensitivity to oxidation and make them better 
fuels. Enzymatic alkene hydrogenation, however, is typi-
cally assisted by adjacent electron-withdrawing groups as 
observed in examples including old yellow enzyme, fatty 
acid enoyl reductases, and enone reductases [17–20].
Reduction of unactivated substrates like prenyl pyroph-
osphates typically involves oxidoreductases from the 
geranylgeranyl reductase (GGR) family. GGR gener-
ates fully saturated isoprenoid intermediates in archaeal 
membrane biosynthesis [21, 22]. In archaea, GGR’s 
native activity is believed to fully reduce all prenyl groups 
within the  C20 isoprenoid chain of 2,3-di-O-geranylgera-
nylglyceryl phosphate (DGGGP) before carbon–carbon 
bond formation of reduced  C20 isoprenoid chains form 
fully reduced  C40 precursors needed for membrane syn-
thesis [23, 24]. Moreover, in various organisms such as 
eukaryotes, bacteria, and archaea, GGRs also have been 
demonstrated to reduce a variety of prenylated sub-
strates, including chlorophyll, tocopherol, dolichol, and 
menaquinone [25–28]. However, very few GGRs have 
been confirmed as oxidoreductases, and most enzymes 
having prenyl reductase activity were derived from spe-
cies that thrive under extremophilic conditions or uti-
lize photosynthesis for energy transduction [25–32]. 
To date, only two crystal structures have been solved 
for GGRs from archaeal organisms. Reducing equiva-
lents are thought to be derived from a NAD(P)H/ferre-
doxin reductase, in which electron transfer is conducted 
throughout the protein and modulated by a conserved 
active site cysteine within the cofactor binding domain, 
located directly behind the FAD isoalloxazine ring [31].
Biomanufacturing of reduced isoprenoid compounds 
requires a reductase activity under biologically relevant 
conditions required by bacterial and yeast strains (i.e., at 
30–37  °C, at pH 7). In this study, we sought to increase 
the diversity space of GGRs by testing several dozen 
putative GGR sequences across a broad phylogeny, and 
we proceeded to test their associated substrate promis-
cuities under conditions ideal for microbial manufactur-
ing (Scheme  1). Herein, we present significant insights 
on GGR activities that encompass newly confirmed GGR 
enzymes, novel substrate activities, and promiscuous 
catalysis.
Results and discussion
Selection and expression of potential GGR candidates
The Interpro database (EMBL-EBI) predicts over 8000 
proteins present within the GGR family (InterPro code: 
IPR011777), with many homologous genes containing 
sequence identities as low as 20–30%. After sequence 
alignment, a phylogeny tree includes 1787 sequences 
of predicted GGR from the InterPro database. A few 
GGRs within this database have been confirmed by other 
groups to reduce a wide variety of large prenylated sub-
strates, including GGPP, DGGGP, geranylgeranylchloro-
phyll, menaquinone, and dolichol [25–32]. To investigate 
the in  vitro prenyl reductase potential of other genes 
within the GGR family, we selected some with conserved 
sequence homologies to known GGRs and other more 
distant sequences. As observed in Fig. 1, it was possible 
to observe some subgroups with conserved sequences 
(e.g., Mc, Sa, Pf or Hl, Hv1, Hs). Most of the sequences 
in the predicted GGR family, however, are very divergent. 
Our selection was then based on kingdom and diver-
sity of species (e.g., archaea, algae, plant, cyanobacteria, 
and bacteria), on environmental diversity (e.g., tempera-
tures, pH, aerobic or anaerobic), as well as particular 
Scheme 1 Products formed from prenyl alcohols (top) or pyrophosphates (bottom) when incubated with GGR 
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Fig. 1 Phylogenetic tree representing the diversity of the GGR family of enzymes. The tree includes 1787 sequences of predicted GGRs from the 
InterPro database. Putative GGRs were selected from various organisms encompassing archaea (red), bacteria (purple), cyanobacteria (blue), alga 
(cyan), and plants (green). Black circles represent GGRs selected to test for isoprenoid reductase activity within this study; orange circles represent 
soluble proteins successfully purified and tested for reductase activity. The organismal abbreviations are listed described in Table 1
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characteristics of some strains (e.g., Corynebacterium 
terpenotabidum or Gordonia polyisoprenivorans are 
actinomycetes capable of degrading squalene and rubber 
reciprocally). A few GGRs were also selected more ran-
domly for their atypical sequences (Fig. 1).
The 31 selected genes were codon optimized for E. coli 
expression and were all successfully transformed into E. 
coli. Initial expression attempts were not successful for 
many proteins using E. coli BL21 (DE3). However, by E. 
coli BL21 (DE3) strain harboring the commercially availa-
ble pG-KJE8 plasmid overexpressing several E. coli chap-
erones, 24 of 31 strains overexpressed soluble proteins 
at the target masses for each protein, with each protein’s 
presence in cell lysates confirmed by western blot con-
taining the anti-His tag antibody (Fig.  2). Out of them, 
only 12 proteins (Af, Cn, Ma, Mb, Mi, Mr2, Pf, Sa, Sc, 
Syn, Ta, and Tn) were obtained in sufficiently large quan-
tities needed for activity assays after a standard purifica-
tion and concentration process conducted at pH 7.4.
In vitro activity with isoprenoid alcohols
The 12 soluble proteins successfully isolated were tested 
for reductase activity on GGOH and FOH, and products 
obtained after enzymatic incubation were analyzed by 
GC–MS.
Out of the 12 purified GGRs, five were discovered to 
enzymatically reduce geranylgeraniol (GGOH). Neat 
GGOH substrate eluted at a retention time (RT) of 
8.4 ± 0.1 min (Fig. 3), with a directly proportional TIC 
response ranging from 0 to 200  µM (Additional file  1: 
Figure S1). Upon incubation with any of five putative 
GGRs isolated from Archaeoglobus fulgidus (AfGGR), 
Methanocaldococcus infernus (MiGGR), Pyrolobus 
fumarii (PfGGR), Thermococcus nautili (TnGGR), 
or Sulfolobus acidocaldarius (SaGGR), several peaks 
eluting earlier than 8.4  min were observed (Fig.  3). 
These peaks were assigned to structures of  H2-GGOH 
(RT = 8.1 ± 0.1  min),  H4-GGOH (RT = 7.9 ± 0.1  min), 
and  H6-GGOH (RT = 7.7 ± 0.1 min). Moreover, as pro-
tein concentration was increased, substrate consump-
tion accelerated (Additional file  1: Figure S2) with a 
concomitant increase in the formation of the various 
product peaks (data not showed), confirming enhanced 
isoprenoid reduction in the presence of higher concen-
tration of enzymes. Out of all enzymes tested, SaGGR 
was the most active toward GGOH, with a specific 
activity of at least 50 ± 10  nmol terpenoids reduced 
per milligram of enzyme per hour (Fig. 4 and Table 2). 
Typically, 70% of the initial GGOH would be recovered 
regardless of the varying amounts of reduced prod-
uct formed. Hence, we assumed that all unrecovered 
substrate was unreduced, and the turnover numbers 
presented herein most likely represent a lower bound 
for reductase activity. 
The  H2-GGOH and  H4-GGOH peaks have respective 
prevalent ion abundances at 261 and 263 m/z, which can 
be achieved by loss of a 31  Da [M–CH2OH] fragment 
during ionization and subsequent formation of a reso-
nance-stabilized singly or doubly reduced geranylgeranyl 
fragment. Such fragments most likely originate from the 
prenyl units distal from the alcohol group being reduced 
first, in accordance with previous mechanistic proposals 
performed using various substrates on a variety of GGRs 
[29, 32, 33]. Moreover, the  H6-GGOH peak matches with 
a phytol peak from the NIST database with > 90% proba-
bility, further reinforcing a mechanism of serial reduction 
of substrate beginning with the δ-prenyl group. Inter-
estingly, several GGRs exhibit unknown side-products, 
with the most prevalent behavior observed between the 
 H2-GGOH and  H4-GGOH peaks in Pyrolobus fumarii 
GGR (RT = 8.0 min) (Fig. 3). This peak contains aberrant 
patterns for prenyl units within m/z window of 50–100, 
and we suggest these are  H4-GGOH regioisomers in 
which one or both internal prenyl units are reduced first, 
which was suggested from the NIST database with > 80% 
probability (Additional file 1: Figure S3).
Of most noteworthy interest is the product eluted at 
7.5 ± 0.1  min RT from assays containing GGRs from 
Sulfolobus acidocaldarius (Fig.  3). The mass spectra are 
matched against the 3,7,11,15-teramethylhexadecan-
1-ol compound, a complete hydrogenation product of 
GGOH, in the NIST database with > 88% probability. 
SaGGR, among others, has been demonstrated to reduce 
3 out of 4 prenyl units of GGPP at best as observed in 
this work and others [29, 33]. Because a complete reduc-
tion is not observed in isoprenoid pyrophosphate sub-
strates (Fig. 5) but is observed in the isoprenoid alcohol 
(Fig.  3), it seems that the absence of phosphate groups 
might facilitate enhanced diffusion of the α-prenyl group 
to the flavin reducing site in the alcohol substrates, lead-
ing to a fully reduced product. To our knowledge, this is 
the first evidence of any nonnative isoprenoid substrate 
undergoing full reduction by any known or putative GGR 
enzyme.
Similarities in reducing activity were also prevalent 
using farnesol as a substrate. The unreduced FOH sub-
strate eluted with a RT of 8.0 ± 0.1 min, with the putative 
singly  (H2-FOH) and doubly reduced  (H4-FOH) farnesol 
eluting at 7.6 ± 0.1  min and 7.4 ± 0.1  min, respectively 
(Fig. 6). Farnesol ionization was also directly proportional 
to concentration ranging from 0 to 200  µM (Additional 
file  1: Figure S1). The accompanying mass spectrum 
for  H2-FOH reveals a similar ionization pattern to that 
observed in  H2-GGOH via the prevalence of a strong 
193 m/z peak. This parallels the  H2-GGOH peak pattern 
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containing one less prenyl group (m/z = 70 Da). This sug-
gests that the terminal isoprenoid unit is also reduced 
first in farnesol, conserving the enzymatic reduction 
mechanism regardless of substrate. The  H4-FOH peak at 
7.4 min more closely resembles the  H6-GGOH peak, with 
identical peak groupings near the 71, 81, and 123  m/z 
parent fragments.
Unlike GGOH, all GGRs appeared to have similar lev-
els of FOH products under standard assay conditions, 
exhibiting an average specific activity of 7 ± 2 nmol ter-
penoid groups reduced  mg−1  enzyme  h−1 (Fig.  4 and 
Table 1). Notably, reduction patterns in TnGGR on FOH 
differ slightly from the other GGRs under standard assay 
conditions, as its major product is  H2-FOH instead of 
 H4-FOH (Fig.  4). No fully reduced farnesol peaks were 
observed under standard assay conditions nor at enzyme 
concentrations as high as 150  µM at pH 7.4. However, 
SaGGR generated a modest amount of  H6-FOH when 
incubated under the enzyme’s optimal conditions at 50 °C 
and pH 5.5 [33] (Additional file 1: Figure S4).
Compared to GGOH, emergent side products are less 
prevalent in the farnesol TICs. Whereas multiple peaks 
were observed between the singly and doubly reduced 
GGOH (Fig. 3), a single prevalent peak at 7.8 min elutes 
between FOH and  H2-FOH, mainly observed when incu-
bated in the presence of Pf and MiGGR (Fig.  6). The 
associated mass spectrum is tentatively assigned to a 
regioisomer of  H2-FOH where the middle prenyl unit is 
Table 1 Table of proteins tested for potential enzymatic isoprenoid reductase activity
The molecular weight of the enzymes includes the N-terminal His tag sequence
GGR name Organism Type INTERPRO number Molecular weight (kDa)
AfGGR Archaeoglobus fulgidus #1 Archaea >A0A075WA57 44
Af2GGR Archaeoglobus fulgidus #2 Archaea >A0A075WDX8 42
AtGGR Arabidopsis thaliana Plant >Q9CA67 49
CnGGR Candidatus Nitrosopumilus Archaea >K0BBV2 47
CtGGR Corynebacterium terpenotabi-
dum
Bacteria >S4XGC5 49
GpGGR Gordonia polyisoprenivorans Bacteria >H6N2C4 46
HcGGR Halorubrum californiensis Archaea >M0EA67 41
HlGGR Halostagnicola larsenii X Archaea >W0JLI3 52
HsGGR Haloterrigena salina Archaea >M0BU08 53
Hv1GGR Haloferax volcanii #1 Archaea >D4GXW9 53
Hv2GGR Haloferax volcanii #2 Archaea >D4H022 41
Ma1GGR Methanosarcina acetivorans #1 Archaea >Q8TQQ6 46
Ma2GGR Methanosarcina acetivorans #2 Archaea >Q8TLY0 47
Ma3GGR Methanosarcina acetivorans #3 Archaea >Q8TSV3 45
MbGGR Methanococcoides burtonii Archaea >Q12WF0 46
McGGR Metallosphaera cuprina Archaea >F4FYK4 53
MiGGR Methanocaldococcus infernus Archaea >D5VQY0 45
MmGGR Methanococcus maripaludis Archaea >Q6LXX0 45
Mr1GGR Methanobrevibacter ruminan-
tium #1
Archaea >D3E3T0 45
Mr2GGR Methanobrevibacter ruminan-
tium #2
Archaea >D3E430 51
NgGGR Nitrososphaera gargensis Archaea >K0IKB9 43
PcfGGR Pyrococcus furiosus Archaea >Q8U3L2 43
PfGGR Pyrolobus fumarii Archaea >G0EHJ8 53
SaGGR Sulfolobus acidocaldarius Archaea >M1I414 52
ScGGR Streptomyces coelicolor #1 Bacteria >Q9K426 47
SeGGR Synechococcus elongatus #1 Cyanobacteria >Q31QX9 43
SynGGR Synechocystis species Cyanobacteria >L8ATV2 47
TaGGR Thermoplasma acidophilum #1 Archaea >Q9HKS9 45
TnGGR Thermococcus nautili Archaea >W8NRH6 46
Tr1GGR Thermocrinis ruber #1 Bacteria >W0DGJ3 41
Tr2GGR Thermocrinis ruber #2 Bacteria >W0DID8 42
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reduced first (Additional file 1: Figure S5). The spectrum 
matches the NIST database for (E)-3,7,11-trimethyldo-
deca-2,10-dien-1-ol with a probability of 85% (Additional 
file  1: Figure S5). Many of the aberrant mass groupings 
between 50 and 100  m/z (Additional file  1: Figure S5) 
parallel those observed in the GGOH reaction incubated 
with PfGGR (Additional file 1: Figure S3). However, the 
7.8-min peak does not contain the m/z 193 ion. This ion 
could be formed by cyclization of a [M–CH2OH] frag-
ment containing a reduced terminal prenyl group and is 
absent in products where the middle group is reduced 
first due structural rigidity associated with the remnant 
α- and γ-prenyl groups. This observation, coupled with 
the aberrant TIC product profile observed with GGOH, 
suggests a promiscuous mechanism in which PfGGR has 
been observed to reduce prenyl monomers out of order 
with respect to their polymeric structural order.
In vitro activity with isoprenoid pyrophosphates
The 12 soluble GGRs successfully purified were tested 
for reductase activity on FPP and GGPP, and products 
were detected by LC–MS–TOF. Both farnesyl pyroph-
osphate (FPP, m/z = 381.123 ± 0.001  Da) and geranylge-
ranyl pyrophosphate (GGPP, m/z = 449.183 ± 0.002  Da) 
standards eluted with a retention time of 1.70 ± 0.05 min 
(Fig. 5); both substrates produced linear standard curves 
over a concentration range of 0–120  µM (Additional 
file  1: Figure S6). When incubated with GGR under 
standard assay conditions, reduced isoprenoid products 
were observed to co-elute with fully oxidized substrate 
under isocratic LC conditions. Therefore, only normal-
ized LC–MS–TOF spectra were utilized to distinguish 
the relative levels reduced and oxidized compounds that 
co-elute after incubating with GGRs isolated from vari-
ous species (Additional file 1: Table S1).
Interestingly, all proteins in this study discovered to 
enzymatically reduce prenyl pyrophosphates revealed 
co-eluting side products indicative of substrate or 
product hydrolysis of one phosphate moiety (Fig.  5). 
Increased abundances of farnesyl monophosphate (FP, 
m/z = 301.177 ± 0.001 Da) or geranylgeranyl monophos-
phate (GGP, m/z = 369.213 ± 0.003  Da) only emerged 
when incubated with enzyme; minimal hydrolysis was 
observed in GGPP or FPP standards and relative GGPP/
GGP and FPP/FP ratios remained constant as a function 
of time in negative controls ran without enzyme (Addi-
tional file  1: Figure S7). Structural studies of SaGGR 
crystallized with GGPP revealed three distinct sub-
strate binding modes with varying degrees of phospho-
rylation within each binding position [33]. Within the 
Fig. 2 Various putative GGR’s expression in E. coli BL21 (DE3) harboring the pG-KJE8 plasmid. SDS-PAGE (top) and Western blot using anti-His 
antibody (bottom) verify protein overexpression in crude lysates at the expected masses. Only 26 out of the 31 selected GGR are shown in this 
figure
Fig. 3 (Top) normalized TIC profiles of five putative GGRs (Af, red; Pf, green; Mi, blue; Sa, magenta; Tn, orange; no enzyme, black) found to reduce 
GGOH (RT = 8.31 min) to  H2-GGOH (RT = 8.12 min),  H4-GGOH (RT = 7.85 min),  H6-GGOH (RT = 7.72 min), and  H8-GGOH (RT = 7.52 min) upon 1 h 
incubation under standard assay conditions. All peaks elute with a relative error of ± 0.05 min. (Bottom) the associated mass spectra for GGOH 
(blue),  H2-GGOH (green),  H4-GGOH (red),  H6-GGOH (orange),  H8-GGOH (gray) are shown with signature ions used for structural assignment of 
products
(See figure on next page.)
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catalytically relevant binding mode, both phosphate moi-
eties are resolved. In the other two binding modes, how-
ever, either one or zero phosphate group was structurally 
resolved. This was attributed to dephosphorylation dur-
ing the crystallization process [33]. Herein, we observed 
a time-dependent emergence of hydrolyzed monophos-
phate products via LC–MS–TOF; yet it still requires 
further characterization how the enzyme facilitates this 
phenomenon while conducting substrate reduction.
Reductase activity on FPP and GGPP varied from what 
was observed on alcohol substrates (Fig. 7). Indeed, none 
of the GGRs tested could significantly reduce all vinyl 
groups within FPP or GGPP even when GGRs were incu-
bated under the optimal condition for enzyme activity (at 
50 °C and pH 5.5) (data not shown). Out of the five GGRs 
found to reduce FOH, only PfGGR, TnGGR, and SaGGR 
could reduce FPP. On the other hand, three GGRs iso-
lated from Streptomyces coelicolor (ScGGR), Metha-
nosarcina acetivorans (MaGGR), and Thermoplasma 
acidophilum (TaGGR) were found to reduce GGPP along 
with the five GGRs demonstrating reductase activity 
toward GGOH. Most GGRs that have been isolated thus 
far were from archaea; to our knowledge, ScGGR is the 
first bacterial GGR demonstrated to reduce GGPP. Due 
to unexpected hydrolysis of one phosphate moiety under 
standard assay conditions, specific activities for reduc-
tion were not quantified for any GGR. However, relative 
reductase activities can be gleaned by quantifying the 
proportion of reduced and unreduced compounds pre-
sent within intact or hydrolyzed mass groupings (Fig. 7). 
For example, the relative ion intensities of each singly 
reduced product  (H2-FPP or  H2-FP) present is normal-
ized to the sum of FPP,  H2-FPP,  H4-FPP,  H6-FPP, FP, 
 H2-FP,  H4-FP, and  H6-FP extracted ion intensities.
Interestingly, all GGRs revealed a larger proportion of 
reduced products present as hydrolyzed moieties than 
non-hydrolyzed moieties (Fig. 7). To discern a correlation 
between enzymatic phosphate hydrolysis and enzymatic 
reduction of prenyl monophosphates, we assayed PfGGR 
and SaGGR as a function of time, as these enzymes are 
representative of low and high amounts of monophos-
phate found after standard assay incubation, respectively 
(Additional file 1: Figure S7). Indeed, substrate hydroly-
sis appears to react as a first-order exponential process 
which occurs more quickly in SaGGR than for PfGGR 
(Additional file 1: Figure S8). Moreover, the relative abun-
dances of reduced monophosphate products increase 
over time in both assays, indicating that most GGRs can 
still reduce FP or GGP as a substrate during substrate 
hydrolysis (Additional file  1: Figure S9). Such an infer-
ence is reasonable considering many GGRs assayed enzy-
matically reduce terpenoid alcohols and pyrophosphates.
Promiscuous hydrolysis complicates any interpreta-
tions regarding which enzymes are most active toward 
a given substrate due to the inability to quantify the MS 
response of terpenoid phosphates. However, it can be 
inferred that all GGRs can reduce between 5 and 10 nmol 
prenyl groups of FPP or GGPP  mg−1 enzyme  h−1. The 
turnover number would be modestly elevated for GGPP 
reduction, as all  C20 species are extracted as some 
Fig. 4 Endpoint activity profiles for GGR reduction of either GGOH (left) or FOH (right) incubated under standard assay conditions for 1 h. Product 
distributions are represented as relative percentages of unreduced substrate (blue),  H2-GGOH or  H2-FOH (green),  H4-GGOH or  H4-FOH (red), 
 H6-GGOH or  H6-FOH (orange), and  H8-GGOH (gray)
Table 2 Specific activities of  various enzymatic GGR 
reduction on geranylgeraniol and farnesol
a Units reported in nmol terpene units reduced  mg−1 enzyme  h−1
GGOHa FOHa
Af GGR 22 (5) 9 (2)
MiGGR 10 (2) 8 (2)
PfGGR 9 (1) 7 (1)
TnGGR 20 (5) 5 (1)
SaGGR 50 (10) 8 (1)
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Fig. 5 (Top) normalized MS–TOF spectra for eight putative GGRs (no enzyme, black; Tn, orange; Pf, green; Sa, magenta; Af, red; Mi, blue; Sc, purple; 
Ta, cyan; Ma, brown) found to reduce GGPP (m/z 449–457, highlighted in gray) or GGP (m/z 369–377, highlighted in gray). (Bottom) normalized 
MS–TOF spectra for the three putative GGRs (Tn, orange; Pf, green; Sa, magenta) found to reduce FPP (m/z 381–387, highlighted in gray) or FP (m/z 
301–307, highlighted in gray). Reduced products are signified by abundances present at increases of ca. 2 Da from GGPP, GGP, FPP, or FP
partially reduced product within error after 1  h. Such 
turnover numbers are in line with other reports on GGRs 
with a variety of substrates [32, 33].
Structural insights and mechanistic implications
Several synthetic approaches are currently being 
explored to perform selective hydrogenation on a few 
substrates [34–36]. Biological systems such as enoyl-
CoA reductase and old yellow enzyme exhibit a similar 
oxidoreductase activity to GGR, yet benefit from active 
sites that enhance the electron-withdrawing nature of 
α,β-unsaturated carbonyl substrates [17–20]. Patented 
ene-reductases utilizing old yellow enzyme as a scaffold 
enhance reductase activity on a variety of substrates by 
evolving active sites complementary to a variety of elec-
tron withdrawing groups among a diverse variety of α,β-
unsaturated substrates [37]. However, an evolved GGR 
active site designed for isoprenoid reduction would prob-
ably require significant divergence from these scaffolds 
since they do not utilize electron-withdrawing activation 
for alkene reduction [30].
Of the eight proteins that were identified as GGRs 
active toward terpenoid alcohols and/or terpenoid 
pyrophosphates, five (Sa-, Pf-, Af-, Mi-, and TnG-
GRs) were isolated from archaeal organisms that 
optimally thrive under hyperthermophilic conditions 
(i.e., T ≥ 80 °C). SaGGR, TaGGR, and AfGGR have been 
identified to reduce various large intermediates (i.e., 
larger than 20 carbons) associated with archaeal lipid 
biosynthesis, with GGPP or GGOH serving as the small-
est substrates known to undergo prenyl reduction [27, 
29, 32]. In this study, we have significantly expanded 
the known GGR substrate activity profiles, demonstrat-
ing multiple prenyl group reduction in GGOH and FOH 
within all five hyperthermophilic GGRs.
In addition to the five GGRs active on alcohols, 
TaGGR, MaGGR, and ScGGR also sufficiently reduced 
GGPP or GGP (Figs.  5 and 7). However, only PfGGR, 
SaGGR, and TnGGR were found to reduce the smaller 
FPP or FP substrates. Because the relative amount of 
 H2-,  H4-, and  H6-GGOH increase in relative abundances 
within the monophosphate mass groupings relative to the 
pyrophosphate mass groupings, it can be inferred that 
prenyl monophosphates are also substrates reduced by 
several GGRs (Additional file  1: Figure S9). This seems 
suitable given the ability of several GGRs to reduce pre-
nyl alcohols.
A structural alignment of all eight active GGRs reveals 
very little commonalities among all protein sequences 
with known crystal structures: SaGGR and TaGGR, 
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Fig. 6 (Top) normalized TIC profiles of five putative GGRs (Af, red; Mi, green; Pf, blue; Sa, magenta; Tn, orange; no enzyme, black) found to reduce 
FOH (RT = 8.00 min) to  H2-FOH (RT = 7.58 min) or  H4-FOH (RT = 7.40 min) upon 1 h incubation under standard assay conditions. All peaks elute with 
a retention time error of ± 0.05 min. (Bottom) the associated mass spectra for each peak are shown with signature molecular ions for structural 
assignment of products
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with PfGGR ca. 46% identical to SaGGR and MaGGR, 
MiGGR, and AfGGR ca. 40–46% identical to TaGGR 
(Fig.  8). SaGGR and TaGGR contain three domains: an 
FAD binding domain, a catalytic domain, and a C-ter-
minal domain [29, 30]. While sequence identities remain 
low among all demonstrably active GGRs, certain key 
structural motifs remain conserved within their pre-
dicted FAD binding domains and catalytic domains. Of 
the two known crystal structures of active GGRs, both 
contain an active site cysteine (Cys47 in SaGGR; Cys45 
in TaGGR) thought to serve as a critical redox modulator 
within the active site during reduction. All GGRs shown 
to reduce either isoprenoid alcohols or pyrophosphates 
contain this critical cysteine within their cofactor bind-
ing domains, suggestive of a conserved electron transfer 
mechanism. In addition, all sequences predicted catalytic 
domains contain the YXWXFP (SaGGR residues 215–
220) and GGG motifs (SaGGR residues 298–300) 
believed to modulate substrate interactions and assist in 
substrate diffusion through the reduction center.
Protein structures of aligned sequences were predicted 
using either SaGGR or TaGGR as a template. While 
there is a fair amount of expected structural divergence 
among the structures’ surfaces, a comparison of the 
active sites reveals a fair degree of similarity in topology 
(Fig. 9). However, some of the structural motifs strictly 
conserved among all archaeal GGRs exhibit significant 
divergence within ScGGR, the only known GGR to be 
isolated from a bacterial organism. While all archaeal 
GGRs studied in this work possess a  YXWXFPX7-8GXG 
motif, the terminal glycine is mutated to isoleucine in 
ScGGR. Even more interestingly, the GGG motif has sig-
nificantly diverged to REG in ScGGR. In several GGRs 
from photosynthetic organisms with demonstrated 
capability to reduce prenylated chlorophyll, Rhodobacter 
sphaeroides, Synechocystis sp. PCC 6803, and Arabidop-
sis thaliana, this motif was found to be GEG [26, 38, 39]. 
It seems that non-archaeal GGRs utilize preferentially 
charged residues within this critical catalytic region to 
either enhance polar interactions on prenylated sub-
strates containing polar groups or to introduce criti-
cal hydrogen-bonding interactions that help maintain 
the integrity of the substrate tunnel during reduction 
(Fig. 9).
Mechanistic interpretations from other groups propose 
that the prenyl group closest to the pyrophosphate moi-
ety (α-prenyl group) remains oxidized in GGPP and FPP. 
This observation additionally applies to their monophos-
phate counterparts in this work, FP and GGP. All 
enzymes tested to date seem to conserve this character-
istic of avoiding reduction at the α-position on phosphate 
intermediates, aligning with current paradigms that aux-
iliary prenyl reductases are responsible for reducing this 
group in archaea and eukaryotes [40].
Fig. 7 Endpoint activity profiles for GGR reduction of either GGPP (top) or FPP (bottom) incubated under standard assay conditions for 1 h. Product 
distributions are represented as relative percentages of unreduced substrate (blue),  H2-products (green),  H4-products (red),  H6-products (orange), 
and  H8-products (gray) for intact isoprenoid pyrophosphates (left column), hydrolyzed monophosphates (middle column), and the total intensity 
(right column)
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To our knowledge, full isoprenoid reduction by GGR 
has only been observed with its natural  C40 isoprenoid 
substrate DGGGP. In this work, we observed full reduc-
tion for the first time on smaller (i.e.,  C20 or  C15) isopre-
noid alcohol substrates, namely GGOH and FOH with 
SaGGR (Figs. 3, 4, 6, Additional file 1: Figure S4). Inter-
estingly, the absence of phosphate groups appears to 
assist in full substrate reduction. Analysis of the catalyti-
cally relevant binding mode of GGPP in SaGGR reveals 
that binding site residues His55 and Asn90 could pro-
vide hydrogen bonding interactions with phosphate 
moieties that could prevent the α-prenyl group from 
being reduced [33]. Alcohol substrates may not inter-
act as strongly with these residues, facilitating a degree 
of full reduction unobserved in pyrophosphate sub-
strates. Why some enzymes reduce isoprenoid alcohol 
and pyrophosphate substrates, while others only reduce 
isoprenoid pyrophosphates requires further structural 
characterization.
Conclusions
In this study, we have significantly expanded the possible 
activities among proteins demonstrated to enzymatically 
reduce prenyl pyrophosphates or prenyl alcohols. We 
have demonstrated (1) the discovery of four novel protein 
sequences (PfGGR, MiGGR, ScGGR, and TnGGR) that 
have confirmed GGR activity in  vitro in addition to 
expanded observed activities among previously char-
acterized GGRs; (2) that several GGRs can reduce  C15 
terpenoid substrates, substrates smaller than reported 
substrates for GGR activity; (3) the complete reduction of 
double bonds on any  C20 or  C15 isoprenoid using SaGGR; 
(4) reductase activity on terpenoid monophosphates 
formed from hydrolysis of pyrophosphate substrates 
under reducing conditions in  vitro; (5) the quantifica-
tion of reductase specific activity on terpenoid alcohols; 
and (6) the confirmed isoprenoid reductase activity of the 
second known non-archaeal enzyme, as observed in the 
GGR isolated from Streptomyces coelicolor.
This demonstration of protein expression and reduc-
tase activity at neutral pH and low temperature highlights 
their potential suitability for integration into S. cerevisiae 
or E. coli. Moreover, the confirmation of reduction on  C15 
isoprenoids instantly expands the metabolic engineering 
potential for organisms producing sterol and squalene-
derived isoprenoids. There are still unresolved issues to 
address for a direct application of these newly discovered 
GGRs to manufacture reduced isoprenoids. For example, 
more engineering will be needed on these enzymes to 
avoid enzymatic hydrolysis of isoprenoid pyrophosphates 
Fig. 8 Multiple sequence alignment of proteins shown to enzymatically reduce either  C15 or  C20 prenyl alcohols or prenyl pyrophosphates. Identical 
residues are highlighted in black, similar residues are highlighted in grey, and gaps are represented by dashes
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and to improve their activities especially at mesophilic 
condition. Nonetheless, this study demonstrated signifi-
cant substrate promiscuity among these GGRs and could 
potentially open new pathways for isoprenoid-based pol-
ymers, chemicals, or biofuels by allowing for upstream 
reduction of various intermediates within the heavily uti-
lized MEV or DXP terpene biosynthesis pathways.
Methods
All chemicals and reagent were purchased from Sigma-
Aldrich (St. Louis, MO), unless otherwise indicated. 
(E,E)-farnesol was purchased from Alfa Aesar (Haverhill, 
MA) and glycerol from VWR (Westchester, PA). Solvents 
for high performance liquid chromatography (HPLC) 
were purchased from HoneyWell Burdick and Jackson 
(Morristown, NJ) and were of HPLC grade or higher. 
Ammonium carbonate (30–33%  NH3 basis) was pur-
chased from Fluka Analytical Sigma-Aldrich (St. Louis, 
MO). Restriction enzymes and polymerases were pur-
chased from New England Biolabs (Ipswich, MA).
Sequence analysis and GGR homology
Multiple sequence alignments for potential GGR hits 
were generated using MUSCLE v. 3.8.31 and visual-
ized using Geneious 7.0.6 [41, 42]. Sequences were 
curated manually, and phylogeny trees were computed 
using the maximum likelihood tree within the RAxML 
Software package, v. 8.1.24 under the LG plus gamma 
model of evolution (PROTGAMMALG in the RAxML 
model section) [43]. The MRE-based bootstrapping cri-
terion was automatically determined for phylogeny tree 
construction. Annotation of the tree was performed in 
Itol [44]. After verification of GGR activity, the active 
enzymes underwent a second multiple sequence align-
ment and modeled for their predicted protein structures 
via SWISS-MODEL-PDB using either SaGGR or TaGGR 
as templates [45]. Active site geometries and local struc-
tures for all proteins were visualized using Chimera [46].
Plasmid synthesis and transformation
The gene encoding SaGGR was amplified by PCR from 
the pSKB3-SaGGR plasmid using the forward (5′-GAT 
ATA CAT ATG AAG GAA CTT AAA TAT GAC GTT CTG 
-3′) and reverse (5′-GTC GAC GGA GCT CGA ACT TAA 
ACT TTT GTT AAA CTC TGT TAG AAC-3′) primers syn-
thesized by Integrated DNA Technologies [33]. The PCR 
fragment was digested at the NdeI and SacI restriction 
sites and cloned into the pET-24a vector using the rapid 
DNA ligation kit (Roche). All other putative GGR genes 
were synthesized by GeneWiz (NJ, USA) and similarly 
cloned into the pET-24a vector at the same restriction 
sites. All gene constructs are available through the JBEI 
registry at http://publi c-regis try.jbei.org (Table  1 and 
Additional file 1: Table S2).
Ten nanogram of each plasmid was transformed by 
heat shock at 42 °C for 1 min into chemically competent 
Fig. 9 (Left) overlaid prediction of modeled protein structures of proteins (Sa, cyan; Pf, tan; Af, fuschia; Mi, green; Tn, red; Ta, gray; Sc, magenta; Ma, 
orange) with demonstrated GGR activity using SaGGR (PDB: 4opd) as a template. (Middle) overlaid alignment of protein active sites of residues 
within 10 Å of either the FAD isoalloxazine ring or GGPP substrate. The conservation of the active site cysteine found in all GGRs (cf. Fig. 8) are 
found in proper position to modulate the redox properties of the cofactor. (Right) examination of the ScGGR active site containing the divergent 
REG catalytic motif relative to the GGG motif found in archaeal GGRs. Arg293 and Glu294 of ScGGR make critical intradomain hydrogen bonding 
interactions to accommodate the GGPP binding site
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E. coli BL21 cells harboring the pG-KJE8 plasmid encod-
ing DnaK, DnaJ, GrpE, GroES, and GroEL protein chap-
erones (Takara Bio Inc., Shiga, Japan). Transformed 
cells were recovered in 1  mL of Lysogeny Broth (LB) 
medium (VWR) and incubated for 1 h at 37 °C with shak-
ing at 200 rpm. Following recovery, cells were plated on 
LB Agar containing 50  mg/L of kanamycin (VWR) and 
30  mg/L of chloramphenicol (VWR), and incubated 
overnight at 37 °C. Select colonies were grown overnight 
in LB medium containing 50  mg/L of kanamycin and 
30 mg/L of chloramphenicol and stored in 20% glycerol 
(VWR) at − 80 °C for future use.
Cell culture, protein expression, and protein purification
Overnight seed cultures of 1  mL each were inoculated 
into 400 mL of Terrific Broth (TB) medium supplemented 
with 50 mg/L kanamycin and 30 mg/L chloramphenicol 
and incubated at 37 °C and 200 rpm. At an  OD600 of 0.2–
0.3, chaperone overexpression was induced with 5  ng/
mL tetracycline (VWR) and 2.5  mM arabinose (Sigma-
Aldrich). After the  OD600 reached ≥ 1.0, GGR expression 
was induced with 0.1 mM IPTG (VWR) and incubated at 
18 °C overnight. Cells were pelleted at 6000×g for 10 min 
and immediately lysed using 20  mM phosphate buffer, 
pH 8.0 containing 1 mg/mL lysozyme, 20 mM imidazole, 
200  mM NaCl, and 0.1  mM PMSF protease inhibitor 
(Sigma-Aldrich). After sonication for 10 min, the remain-
ing cell debris was pelleted at 15,000×g for 45 min.
Protein expression was tested for each construct using 
SDS-PAGE and Western blot. For SDS-PAGE analy-
sis, protein samples were normalized for concentration 
using absorbance at 280  nm. Lysates were diluted with 
2× SDS loading dye buffer (Life Technologies, CA, USA) 
containing 10  mM DTT (Sigma-Aldrich) and incubated 
at 98  °C for 20  min. 10  µL of denatured lysate samples 
was loaded onto an 8–16% Tris–Glycine–SDS gradient 
gel (Bio-Rad), and separated using a voltage of 180 V in 
Tris–Glycine–SDS running buffer (Bio-Rad). Gels were 
either directly stained using GelCode Blue Safe Protein 
Stain (Thermo-Fisher) or transferred to a nitrocellulose 
membrane using the trans-Blot Turbo system (Life Tech-
nologies, CA, USA) for analysis by Western blot. Mem-
branes were washed in TBS buffer (50 mM Tris, 150 mM 
NaCl, pH 7.4) and blocked overnight at 4 °C with 25 mL 
of 3% BSA in TBS-Tween20 (Sigma-Aldrich). The mono-
clonal mouse anti-His primary antibody (Sigma-Aldrich) 
was diluted 5000-fold, and an alkaline phosphatase-
conjugated goat anti-mouse secondary antibody was 
diluted 10,000-fold in TBS-Tween20 containing 1% BSA. 
Membranes were incubated with antibodies for 1 h each 
at room temperature and washed three times in TBS-
Tween20 after each antibody incubation. The membrane 
was then incubated in 10  mL of SigmaFast BCIP/NBT 
Alkaline Phosphatase detection solution (Sigma-Aldrich) 
for 10 min.
To further characterize those putative GGRs that 
showed significant protein expression, the cells harbor-
ing them were cultured in 400 mL of TB-Kan/Cm media 
and lysed as previously described. Their respective crude 
lysates were loaded directly onto a 1  mL HisTrap Fast-
Flow column (GE Healthcare), washed with ten column 
volumes of 20 mM phosphate buffer containing 20 mM 
imidazole and 200  mM NaCl at pH 7.4, then eluted 
with the same buffer containing 240 mM imidazole. For 
enzyme kinetics, purified enzymes were buffer exchanged 
using 20  mM phosphate buffer at pH 7.4 and concen-
trated to 200–800  μM using 30  KDa molecular weight 
cutoff spin concentrators (EMD Millipore). Purified pro-
teins were stored in 10% (v:v) glycerol and snap frozen in 
liquid nitrogen. Protein purity and sizes were verified by 
SDS-PAGE and protein concentrations were quantified 
by absorbance at 280 nm using each protein’s calculated 
extinction coefficient via the ExPASY ProtParam tool.
In vitro enzyme kinetics assays
Validation of enzymatic substrate reduction was deter-
mined by incubating all assays in triplicate for each 
respective substrate and putative GGR for 1 h at 37 °C. All 
assays were performed at pH 7.4 in 100 mM sodium phos-
phate buffer containing 30–150 µM enzyme, 200 µM FAD 
(Sigma-Aldrich), and 65  mM sodium dithionite (Sigma-
Aldrich). Standard assays for alcohol reduction were incu-
bated with 100  µM enzyme and 500  µM (E,E)-farnesol 
(Alfa-Aesar) or (E,E,E)-geranylgeraniol (Sigma-Aldrich); 
pyrophosphate assays were performed at 100  µM FPP 
or GGPP (Sigma-Aldrich). Alcohol-based assays were 
quenched by liquid extraction using a 3:1 (v:v) LC-grade 
ethyl acetate solution containing 100 µM dodecanol as a 
GC internal standard (Sigma-Aldrich). The organic layer 
was extracted and stored at − 20 °C until analysis by GC–
MS. Pyrophosphate assays were similarly quenched using 
LC-grade n-butanol (Sigma-Aldrich) 1:1 (v:v) and cen-
trifuged at 15,000×g for 2 min. The n-butanol layer was 
dried for 45  min at ambient temperature using a Lab-
conco speedvac, reconstituted in 25  µL of a 62:38 (v:v) 
acetonitrile/50  mM ammonium carbonate solution, and 
stored at − 20  °C until further analysis by LC–MS–TOF 
[33]. Characterization of enzymatic hydrolysis of isopre-
noid pyrophosphate substrates by SaGGR and PfGGR was 
performed by quenching the enzyme reactions at 0, 2, 5, 
10, 20, 40, and 60 min of incubation.
Analysis of alcohol reduction by GC–MS
Product identification and quantification of farnesol and 
hydrofarnesol derivatives were modified from previous 
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detection methods [47]. All GC–MS analyses were deter-
mined using an Agilent 6890 gas chromatography instru-
ment coupled to an Agilent 5973 mass selective detector. 
1 µL of extracted samples was injected in splitless mode 
onto an Agilent CycloSil-B column, with helium used 
as a carrier gas flowing at 1.0  mL/min. Following injec-
tion, the oven was held at 50 °C for 30 s, then increased 
to 175 °C at 35 °C/min. Farnesol and hydrofarnesols were 
resolved by increasing the temperature 4  °C/min up to 
200  °C, then increased to 300  °C at a rate of 35  °C/min 
where it was held for 1.5  min. Geranylgeraniol and its 
hydrogenated derivatives were analyzed using the same 
injection method. After injection, the oven was held at 
50  °C for 30  s, then increased to 235  °C at 35  °C/min. 
Hydrogeranylgeraniols were separated by increasing 
the oven temperature 4  °C/min to 250  °C, then ramped 
to 300  °C at a rate of 35  °C/min where it was held for 
1.5 min.
The EI–MS detection was initiated after a solvent delay 
of 5.0 min. Detection and classification of hydrofarnesols 
were performed in scan mode at 9.8 scans/s ranging from 
50 to 250 m/z in positive ion mode. For geranylgeraniol, 
the same scan parameters were implemented except for 
the mass range, which was expanded to 50–300  m/z in 
positive ion mode. The electron multiplier voltage was set 
to a gain factor of 1, with the MS ion source and quadru-
pole set to 230 °C and 150 °C, respectively.
Total ion chromatograms (TIC) were integrated using 
Agilent Technologies Masshunter software, version 6. 
Product formation was determined from the TIC area 
for  C15 or  C20 alcohol products eluting at each respec-
tive retention time. Absolute product concentrations 
were determined from standard curves (0–200  µM) of 
either farnesol or geranylgeraniol assuming the TIC area 
of each reduced product ionizes with an equivalent effi-
ciency to that of the unreduced substrate (Additional 
file  1: Figure S1). Subsequently, enzyme turnover num-
bers for isoprenoid reduction were calculated as the total 
number of nanomoles of prenyl units reduced per milli-
gram of enzyme in 1 h.
Analysis of pyrophosphate reduction by LC–MS–TOF
The separation of FPP, GGPP, and their reduced forms 
was conducted on a ZIC-pHILIC column (150  mm 
length, 2.1  mm internal diameter, and 5  µm particle 
size, Merck) using an Agilent Technologies 1200 Series 
Rapid Resolution high-performance liquid chromatogra-
phy (HPLC) system. Solvents for HPLC were purchased 
from HoneyWell and were of HPLC grade or higher. The 
mobile phases used for this analysis were (A) 50  mM 
ammonium carbonate (Fluka, 30–33%  NH3 basis) in 
water and (B) acetonitrile. Analytes were eluted isocrati-
cally with a mobile phase composition of 62% B at a flow 
rate of 0.2 mL/min. The total run time of the method was 
6.5  min. The temperature of the sample tray was main-
tained at 6 °C using an Agilent FC/ALS Thermostat. The 
column compartment was set to 40  °C. A sample injec-
tion volume of 2 µL was used throughout [33].
The HPLC system was coupled to an Agilent Technolo-
gies 6210 time-of-flight mass spectrometer (LC–TOF–
MS) by a 1/3 post-column split. Contact between both 
instrument set-ups was established using a LAN card to 
trigger the MS into operation upon the initiation of a run 
cycle from the MassHunter workstation (Agilent Tech-
nologies). Electrospray ionization (ESI) was conducted in 
the negative ion mode and a capillary voltage of − 3500 V 
was utilized. MS experiments were carried out in full 
scan mode, at 0.86 spectra/second for the detection of 
[M−H]− ions. The instrument was tuned for a range of 
50–1700 m/z. Prior to LC–TOF–MS analysis, the TOF–
MS was calibrated via an ESI-L low concentration tuning 
mix (Agilent Technologies).
Data acquisition and processing were performed by 
the Agilent Technologies MassHunter software pack-
age. Product formation was determined using extracted 
ion chromatogram abundances (± 0.02  Da) for each 
molecule’s [M−H]− mass (Additional file  1: Table  S1). 
Substrate and product hydrolysis of SaGGR and PfGGR 
was characterized as a function of time by measuring 
the relative ratios of prenyl pyrophosphates (FPP/GGPP 
and reduced products) and monophosphates (FP/GGP 
and reduced products) at quenched fractions collected at 
0, 2, 5, 10, 20, 40, and 60  min. Relative reductase reac-
tivity among GGRs was determined by measuring the 
fractional abundance of singly, doubly, or triply reduced 
products to the total ion abundance present for intact 
and hydrolyzed moieties [33]. Integrated areas for hydro-
lyzed monophosphate products were assumed to have 
the same ionization intensities as their pyrophosphate 
counterparts, as determined by their standard curves 
measured from 0 to 120 µM (Additional file 1: Figure S6).
Additional file
Additional file 1: Figure S1. TIC for neat GGOH (RT = 8.4 min, top) and 
FOH (RT = 8.0 min, middle) substrates. The standard curve for quantify-
ing farnesol (circles) and geranylgeraniol (squares) by GC–MS (bottom) 
exhibited a linear response for both substrates between 0 and 200 µM. 
Figure S2. Verification of accelerated substrate reduction as a function of 
enzyme concentration for GGOH (left) and FOH (right) for the Af (circles), 
Mi (squares), Tn (filled triangles), Sa (filled upside down triangles), and Pf 
(unfilled triangles) GGR enzymes. Specific activities are quoted in Table 1. 
Figure S3. Comparison of mass spectra between a side product contain-
ing one internal prenyl group reduced within  H4-GGOH with an 8.0 min 
retention time (Top, black) and the assigned product with the terminal 
prenyl group reduced in  H4-GGOH eluting at 7.7 min (Bottom, green). 
Figure S4. (Top) normalized TIC of farnesol activity assay incubated for 
2 h with SaGGR at 50 °C, pH 5.5 showing a modest abundance of fully 
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reduced farnesol (RT = 7.0 ± 0.1 min). For reference, FOH and  H4-FOH 
elute at retention times of 7.9 and 7.3 min, respectively.  H2-FOH 
(RT = 7.5 min) was not observed in any quantifiable abundance. All 
substrate and cofactor concentrations were held constant. Figure 
S5. Comparison of mass spectra between the middle prenyl group 
reduced within the putative  H2-FOH side product eluting at 7.8 min 
retention time (Top, black) and the assigned product with the terminal 
prenyl group reduced in  H2-FOH eluting at 7.6 min (Bottom, green). 
Figure S6. Standard curve for quantifying FPP (circles) and GGPP 
(squares) by LC–MS–TOF. Figure S7. MS-TOF Spectrum of 100 µM FPP 
and GGPP standards (Top). (Bottom) relative abundances of GGPP and 
GGP (left) or FPP and FP (middle) after incubation under standard assay 
conditions; negative controls containing all assay components without 
enzyme (right) rule out the possibility of spontaneous hydrolysis of 
substrate, as the ratio of pyrophosphate (dark gray) to monophosphate 
(light gray) products remain constant as a function of time. Reduced 
products within each mass grouping are included in the total abun-
dance. Figure S8. Demonstration that first-order substrate hydrolysis 
catalyzed by either SaGGR (squares) or PfGGR (triangles) in either FPP 
(left) or GGPP (right). The no enzyme control (circles) contained all 
assay components except enzyme. Figure S9. Timecourse comparison 
of the standard assay for SaGGR (top row) and PfGGR (bottom row) on 
either GGPP or FPP substrates. Pyrophosphate abundances are shown 
in the left column and monophosphate abundances are shown in the 
right column under each substrate. Products are expressed as having 
zero reductions (blue), one reduction (green), two reductions (red), or 
three reductions (orange). Table S1. Masses used to analyze various 
products formed from GGR standard assays incubated with prenyl 
pyrophosphates. aMasses reported are for the deprotonated [M−H]− 
parent ion in negative mode detection. Table S2. Table of plasmids 
used in the present study. The strains harboring individual plasmid are 
available at the public registry of the Joint BioEnergy Institute (https ://
publi c-regis try.jbei.org/) under the ID’s listed in the righthand column.
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